Dexcom earnings were $571.5M for the trailing 12 months ending Jun 30, 2025, with -15.2% growth year over year. The latest DXCM earnings report on Jun 30, 2025 announced Q2 2025 earnings of $179.8M, up 70.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DXCM reported annual earnings of $576.2M, with 6.4% growth.
DXCM past earnings growth
How has DXCM's earnings growth performed historically?
On DXCM's earnings call on Invalid Date, Dexcom (NASDAQ: DXCM) reported Q2 2025 earnings per share (EPS) of $0.46, up 27.78% year over year. Total DXCM earnings for the quarter were $179.80 million. In the same quarter last year, Dexcom's earnings per share (EPS) was $0.36.
As of the last Dexcom earnings report, Dexcom is currently profitable. Dexcom's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $571.50 million, a 14.3% decrease year over year.
What was DXCM's earnings growth in the past year?
As of Dexcom's earnings date in Invalid Date, Dexcom's earnings has grown -15.2% year over year. This is 100.4 percentage points lower than the US Medical Devices industry earnings growth rate of 85.19%. DXCM earnings in the past year totalled $571.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.